NIH-funded research NIH-funded research

Dynamic single-cell analysis instrument ready to help labs map how individual cells behave

Official title: Dynamic single-cell analysis instrument commercial readiness (CRP)

Funded at Cellchorus INC. · NIH-11316644 · Data updated 2026-11-12

Aimed at bringing Chronos™—a specialized single-cell timing instrument—into broader use so researchers can watch thousands of live cells and link their behavior to molecular data.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCellchorus INC.
NIH-funded
Lab location1 site (Houston, UNITED STATES)
Project startSeptember 14, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$998,873
NIH project number1SB1GM163323-01
Project IDNIH-11316644 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are researchers and clinicians using single-cell analysis to study cellular dynamics in human biology or disease.

Less likely to help

Patients not involved in or affected by single-cell instrument development or commercialization may not directly benefit.

What this research studies

This project focuses on commercializing Chronos™, a device designed to study dynamic functions of single cells over time. It seeks to provide automated analysis tools that group cells by behavior, pair phenotypes with molecular data from the same cells, and scale up testing to thousands of cells in parallel. The goal is to overcome current limits where most methods are destructive, only snapshot data, or fail to connect function with molecular identity at the single-cell level. By enabling dynamic, longitudinal observations, researchers can better understand how cells move, interact, and change fate in real time.

Why it matters

Potential benefit: If successful, patients may benefit indirectly from faster development of therapies that rely on understanding individual cell behavior in diseases.

How similar studies have gone: Previous single-cell technologies have shown strong impact, but this project aims to extend dynamic, longitudinal single-cell analysis to population-scale data.

Where this research is happening

  • Cellchorus INC.
    Houston, United States
    Active

Researchers

  • Principal investigator: Meyer, Daniel D — Cellchorus INC.
  • Study coordinator: Meyer, Daniel D

Related research

Other NIH-funded projects on the same topics.

  • LF-TIMING: Large-scale profiling of cell-cell interactions with label-free imaging

    A new high-throughput method to map how immune cells talk to tumor cells and how they move, contact, and kill targets without using labels.

    NIH research Cellchorus INC. · Houston, UNITED STATES · NIH-11381696

  • A new instrument to understand how immune cells work

    This project is developing a special instrument that uses advanced imaging and AI to watch individual immune cells in action, helping us understand how they fight diseases like cancer.

    NIH research Cellchorus INC. · Houston, UNITED STATES · NIH-11323428

  • TIMING: AI-powered single-cell analysis to improve cell therapies

    A patient-facing platform using AI to understand how individual immune cells behave in real time during cell therapy manufacturing, helping create safer and more effective treatments.

    NIH research Cellchorus INC. · Houston, UNITED STATES · NIH-11322109

  • Understanding how immune cells behave to improve cell therapies

    This study is working on a new way to closely watch and understand immune cells used in treatments, so we can see how they behave and grow, helping doctors predict how well these therapies might work for patients before they start.

    NIH research Cellchorus INC. · Houston, UNITED STATES · NIH-11179716

  • Advanced Technology to Understand Immune Cell Behavior

    This project is creating a new technology that uses advanced imaging and artificial intelligence to better understand how individual immune cells work and interact, which can help develop new treatments.

    NIH research Cellchorus INC. · Houston, UNITED STATES · NIH-11136848

  • Profiling how immune cells interact with tumor cells

    This study is testing a new way to look at how immune cells and tumor cells interact, which could help us understand cancer better and improve treatments for patients like you.

    NIH research Cellchorus INC. · Houston, UNITED STATES · NIH-11008612

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.